Hangzhou Hospital of Traditional Chinese Medicine
15
5
6
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Multicenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine Treatment
Role: collaborator
New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway
Role: collaborator
Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
Role: collaborator
Electroacupuncture Treatment for Post-stroke Cognitive Impairment
Role: collaborator
Chinese Real-world Study of Treatment of Vestibular Migraine
Role: collaborator
China Headache and Vertigo Registry Study
Role: collaborator
International Headache Registry Study
Role: collaborator
Prediction of Stroke Risk in Patients with Atrial Fibrillation Based on Chest CT Images
Role: collaborator
Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics
Role: collaborator
Efficacy of Thumb-tack Needle Treatment for Diminished Ovarian Reserve
Role: collaborator
MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance
Role: collaborator
Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine
Role: collaborator
Integrated Rehabilitation in Treating Post-stroke Depression
Role: collaborator
Routine and Deferred Dialysis Initiation
Role: collaborator
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients
Role: collaborator
All 15 trials loaded